Pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that it enclosed copies of the Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2024 of the financial year 2024-25 published on November 15, 2024 in Business Standard and Nav Shakti.
The above information is a part of company’s filings submitted to BSE.